Janux Therapeutics, Inc.

Legend Biotech Corporation

4D Molecular Therapeutics, Inc.

Arcturus Therapeutics Holdings Inc.

Altimmune, Inc.

Black Diamond Therapeutics, Inc.

The global biotechnology market was valued at about $1.65 trillion in 2025 and is projected to grow to $5.22 trillion by 2034 at a compound annual growth rate of 13.67%, according to <a href="https://straitsresearch.com/report/biotechnology-market">Straits Research</a>. The U.S. market remains the largest globally: it was worth $552.39 billion in 2023 and is expected to reach $1.24 trillion by 2030. Insider Monkey has <a href="https://www.insidermonkey.com/blog/20-best-biotech-stocks-under-20-to-buy-now-1685703/">selected</a>&nbsp;20 biotech companies trading below $20 per share that are widely held by hedge funds.

Insider Monkey names 20 under-$20 biotech stocks popular with hedge funds

On the night of Feb. 6, the value of bitcoin briefly approached $60,000 for the first time since October 2024

The crypto market is in a "phase of despair". Why does one strategist believe bitcoin will fall to zero?

Microsoft Corporation

Snowflake Inc.

Salesforce, Inc.

The scale of the selloff in software vendor stocks is perplexing to one of Wall Street's top "technobulls"

Wall Street's chief techno-optimist names 5 stocks to buy in the "soft-apocalypse"

Amazon.com, Inc.

Roblox Corporation

The Boeing Company

Oil stabilized amid expectations of US-Iran talks, which reduced geopolitical risks and weakened the price premium. Bitcoin hit a 16-month low amid a sell-off in technology stocks and investors' risk aversion. These and other topics - in our review of key events for the morning of February 6.

The main thing for the morning: oil stabilized, bitcoin updated the minimum for 16 months

Strategy Inc

Strategy, the largest corporate bitcoin holder, posted a quarterly loss of $12.4 billion

Bitcoin rebounded from the $60,000 level after collapsing 50% from its October peak

Novo Nordisk A/S

Eli Lilly and Company

Hims & Hers Health, Inc.

Shares of Novo Nordisk and Eli Lilly, makers of popular weight-loss drugs, fell in price after Hims &amp; Hers, which owns a telemedicine platform,<a href="https://investors.hims.com/news/news-details/2026/Hims--Hers-Expands-Personalized-Weight-Loss-Portfolio-with-Access-to-Compounded-Semaglutide-Pills-Starting-at-49Month/default.aspx"> announced</a> the launch of its own copy of the Wegovy slimming pill. And it will cost just $49 - three times cheaper than Novo's original, which investors <a href="https://oninvest.com/article/novo-vpecatlil-investorov-zapustiv-v-ssa-tabletku-dla-pohudenia-cto-u-konkurentov">had </a>high hopes for.

Novo Nordisk and Eli Lilly shares plummet: the weight-loss pill will have a $49 copy

Alphabet Inc.

Investors continued to exit risk assets on Thursday, February 5. This led to capital outflow from technology stocks and cryptocurrencies. Additional pressure on the market was exerted by macro data: unemployment in the U.S. was higher than expected. The S&amp;P 500 fell below the values of early January for the first time this year, CNBC <a href="https://www.cnbc.com/2026/02/04/stock-market-today-live-updates.html">noted</a>. And the Nasdaq 100 experienced the worst three-day decline since April, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-02-04/asian-stocks-to-fall-as-tech-led-drop-gains-pace-markets-wrap">writes</a>.

Nasdaq suffered its strongest three-day collapse since April, bitcoin fell in price to $63,000

The competition to expand AI infrastructure could fail all the tech companies involved, warns analyst DA Davidson

Amazon didn't impress the market with the report and announced $200 billion in spending. The stock plummeted

The Estee Lauder Companies Inc.

Shares of American cosmetics manufacturer Estée Lauder collapsed in trading on Thursday, February 5. At the moment, the company's capitalization collapsed by a quarter. This decline is the worst in its history, <a href="https://www.reuters.com/business/retail-consumer/estee-lauder-raises-annual-sales-forecast-2026-02-05/">notes</a> Reuters. Investors reacted to the signal of sluggish demand in the U.S. market, which continues to hamper business recovery and does not meet Wall Street expectations, the agency explains.

Estée Lauder is having its worst day ever: it's down 20% after a weak forecast

Nasdaq, Inc.

Moody's Corporation

FactSet Research Systems Inc.

AI startup Anthropic, whose release of a lawyer automation tool <a href="https://oninvest.com/article/minus-pocti-1-trln-kapitalizacii-za-nedelu-tri-voprosa-o-soft-apokalipsise">triggered a </a>stock crash in software developers and data providers, on Feb. 5 unveiled Claude Opus 4.6, a model that can perform financial analysis and create spreadsheets, the company <a href="https://www.anthropic.com/news/claude-opus-4-6">said </a>in a blog post.

Anthropic and OpenAI released updates in the midst of a market sell-off. Is this a new strike?

Microsoft's cloud service revenue growth slowed to 39%, while Alphabet's rose to 48%

Microsoft received a rare stock downgrade. What worries Stifel analysts?

Morgan Stanley

Until 2025, the bank used Morgan Stanley's services